Two Cancer Specialists on White House Commission on CAM

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 9
Volume 9
Issue 9

WASHINGTON-President Clinton included two cancer specialists on the newly created, 11-member White House Commission on Complementary and Alternative Medicine: George M. Bernier, Jr., MD, hematologist/oncologist, University of Texas Medical Branch in Galveston, and William R. Fair, MD, of Long Boat Key, Fla, former chief of the urology service, Memorial Sloan-Kettering Cancer Center, and emeritus professor of urology, Weill Medical College of Cornell University.

WASHINGTON—President Clinton included two cancer specialists on the newly created, 11-member White House Commission on Complementary and Alternative Medicine: George M. Bernier, Jr., MD, hematologist/oncologist, University of Texas Medical Branch in Galveston, and William R. Fair, MD, of Long Boat Key, Fla, former chief of the urology service, Memorial Sloan-Kettering Cancer Center, and emeritus professor of urology, Weill Medical College of Cornell University.

The commission is charged with developing legislative and administrative recommendations aimed at maximizing the benefits of contemporary and alternative medicine (CAM). Psychiatrist James S. Gordon, MD, director, Center for Mind-Body Medicine, Washington, will chair the commission.

Other members include Sister Charlotte Rose Kerr, RN, of Baltimore, a traditional acupuncture practitioner; Wayne B. Jonas, MD, of the Uniformed Services University of Health Sciences and former director of the NIH Office of Alternative Medicine; Dean Ornish, MD, of Sausalito, California, founder of the Preventive Medicine Research Institute; and George Thomas DeVries III, of Rancho Santa Fe, California, president and CEO of American Specialty Health.

Also, Joseph J. Fins, MD, director of medical ethics, New York Weill Cornell Medical Center; Conchita M. Paz, MD, of Las Cruces, NM, a family medicine specialist; Buford L. Rolin, of Atmore, Alabama, health administrator for the Poarch Band of Creek Indians; Julia Scott, of Washington, DC, president of the National Women’s Health Project; and Thomas Chappell, of Kennebunk, Maine, co-founder of Tom’s of Maine.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content